ARTV — ARTIVA BIOTHERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 75 家机构在其最新 13F 申报中持有 ARTV(ARTIVA BIOTHERAPEUTICS INC),合计申报市值 $420.61M,对应 43.36M 股。按股数计算较上季度增持 82.6%(+13.41M 股),申报市值环比上升 175.0%。持仓集中度较高:前五大持有人占申报市值的 64.4%,前十大的集中度为 82.2%。
与上一季度相比,42 家新建仓位、24 家加仓、2 家减仓、9 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
ARTIVA BIOTHERAPEUTICS INC(ARTV)的主要机构持有人包括 RA CAPITAL MANAGEMENT, L.P.、Blue Owl Capital Holdings LP、Fidelity Management & Research (FMR),按 13F 申报市值在本页 146 家持有人中排名居前。
ARTV 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 ARTV 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 ARTV 的名单——每位投资人按其自身最近一个季度展示。
| 投资人 | 季度 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|---|
|
|
Q2 2026 | 2.60M | $25.26M | 0.07% | 新进 |
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 68 | 18.77M | $227.14M | +136.0% |
| Q2 2026 | 75 | 43.36M | $420.61M | +82.6% |
| Q1 2026 | 42 | 17.15M | $110.47M | -2.5% |
| Q4 2025 | 36 | 17.37M | $74.51M | -3.7% |
| Q3 2025 | 41 | 18.61M | $53.41M | +1.6% |
| Q2 2025 | 49 | 19.03M | $28.73M | -9.5% |
| Q1 2025 | 56 | 22.04M | $66.11M | -0.2% |
| Q4 2024 | 59 | 22.30M | $224.68M | +1.9% |
表内 8 个季度中,机构持股合计减少 16%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2026(+82.6%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.13M | $63.84M | 12.00% | 增持 | |
| 2.88M | $48.12M | 0.00% | 增持 | |
| 1.81M | $21.17M | 0.00% | 增持 | |
| 1.80M | $15.64M | 0.00% | 增持 | |
| 935.72K | $15.63M | 0.02% | 新进 | |
| 672.78K | $11.24M | 1.78% | 新进 | |
| 2.04M | $8.61M | 0.00% | 增持 | |
| 752.56K | $7.47M | 0.00% | 增持 | |
| 396.74K | $5.63M | 0.00% | 增持 | |
| 696.44K | $4.96M | 2.63% | 持有 | |
| 250.00K | $4.17M | 0.19% | 新进 | |
| 268.80K | $3.06M | 0.00% | 增持 | |
| 363.46K | $2.81M | 0.00% | 增持 | |
| 300.00K | $2.14M | 0.10% | 持有 | |
| 299.31K | $2.13M | 26.60% | 持有 | |
| 268.61K | $2.00M | 0.00% | 增持 | |
| 109.83K | $1.12M | 0.00% | 增持 | |
| 60.57K | $1.10M | 0.00% | 新进 | |
| 101.36K | $721.65K | 0.01% | 持有 | |
| 74.08K | $527.43K | 0.00% | 减持 | |
| 49.70K | $441.12K | 0.00% | 增持 | |
| 25.39K | $423.95K | 0.24% | 新进 | |
| 24.09K | $402.35K | 0.03% | 新进 | |
| 20.54K | $343.08K | 0.00% | 新进 | |
| 44.81K | $319.08K | 0.00% | 持有 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.85M | $63.46M | 0.67% | 持有 | |
| 2.35M | $15.16M | 4.21% | 持有 | |
| 1.61M | $10.37M | 0.39% | 持有 | |
| 531.34K | $3.42M | 1.22% | 减持 | |
| 520.33K | $3.35M | 0.00% | 持有 | |
| 299.31K | $1.93M | 2.86% | 持有 | |
| 213.39K | $1.37M | 0.00% | 持有 | |
| 207.69K | $1.34M | 0.00% | 新进 | |
| 194.11K | $1.25M | 0.00% | 持有 | |
| 194.11K | $1.25M | 0.00% | 持有 | |
| 146.37K | $949.82K | 0.60% | 新进 | |
| 123.27K | $793.86K | 0.00% | 减持 | |
| 123.27K | $793.86K | 0.00% | 减持 | |
| 115.04K | $740.86K | 0.00% | 减持 | |
| 101.69K | $655.45K | 0.00% | 增持 | |
| 100.00K | $644.00K | 0.00% | 持有 | |
| 80.04K | $515.45K | 0.00% | 减持 | |
| 39.50K | $254.35K | 0.00% | 减持 | |
| 35.82K | $230.71K | 0.00% | 持有 | |
| 35.00K | $225.40K | 0.01% | 持有 | |
| 32.81K | $211.30K | 0.00% | 新进 | |
| 30.70K | $197.72K | 0.00% | 新进 | |
| 25.00K | $161.00K | 0.10% | 新进 | |
| 23.23K | $149.60K | 0.00% | 新进 | |
| 21.58K | $138.98K | 0.00% | 新进 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.85M | $42.27M | 0.43% | 持有 | |
| 2.35M | $10.10M | 3.17% | 持有 | |
| 1.61M | $6.91M | 0.34% | 持有 | |
| 648.51K | $2.78M | 1.29% | 减持 | |
| 520.33K | $2.23M | 0.00% | 持有 | |
| 299.31K | $1.28M | 1.54% | 新进 | |
| 246.01K | $1.06M | 0.00% | 增持 | |
| 217.10K | $931.35K | 0.00% | 减持 | |
| 217.10K | $931.35K | 0.00% | 减持 | |
| 212.54K | $911.79K | 0.00% | 减持 | |
| 194.11K | $832.72K | 0.00% | 持有 | |
| 194.11K | $832.72K | 0.00% | 持有 | |
| 144.86K | $621.47K | 0.00% | 增持 | |
| 116.20K | $498.50K | 0.00% | 增持 | |
| 101.12K | $434.13K | 0.00% | 减持 | |
| 100.00K | $429.00K | 0.00% | 持有 | |
| 79.56K | $341.31K | 0.00% | 新进 | |
| 40.67K | $174.48K | 0.00% | 新进 | |
| 36.87K | $158.19K | 0.00% | 增持 | |
| 35.82K | $153.69K | 0.00% | 减持 | |
| 35.00K | $150.15K | 0.00% | 持有 | |
| 27.76K | $119.08K | 0.07% | 新进 | |
| 27.07K | $116.14K | 0.00% | 减持 | |
| 21.10K | $90.52K | 0.00% | 新进 | |
| 12.06K | $51.74K | 0.00% | 减持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.85M | $28.28M | 0.35% | 持有 | |
| 2.35M | $6.75M | 2.47% | 持有 | |
| 1.61M | $4.62M | 0.26% | 持有 | |
| 1.15M | $3.30M | 1.87% | 持有 | |
| 798.40K | $2.29M | 0.00% | 增持 | |
| 520.33K | $1.49M | 0.00% | 持有 | |
| 294.42K | $844.99K | 0.00% | 减持 | |
| 262.16K | $752.40K | 0.00% | 减持 | |
| 262.16K | $752.40K | 0.00% | 减持 | |
| 194.11K | $557.09K | 0.00% | 持有 | |
| 194.11K | $557.09K | 0.00% | 持有 | |
| 159.12K | $456.67K | 0.00% | 减持 | |
| 118.55K | $340.23K | 0.00% | 增持 | |
| 110.90K | $318.51K | 0.00% | 减持 | |
| 105.57K | $303.00K | 0.00% | 增持 | |
| 100.00K | $287.00K | 0.00% | 持有 | |
| 79.15K | $227.15K | 0.00% | 新进 | |
| 59.82K | $171.69K | 0.00% | 减持 | |
| 49.78K | $142.86K | 0.00% | 减持 | |
| 47.97K | $137.68K | 0.01% | 新进 | |
| 42.83K | $122.92K | 0.00% | 减持 | |
| 39.13K | $112.31K | 0.01% | 新进 | |
| 35.00K | $100.45K | 0.00% | 持有 | |
| 26.95K | $77.00K | 0.00% | 减持 | |
| 25.55K | $73.33K | 0.00% | 减持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.85M | $14.88M | 0.25% | 持有 | |
| 2.35M | $3.55M | 1.37% | 持有 | |
| 1.61M | $2.43M | 0.18% | 持有 | |
| 1.15M | $1.73M | 1.51% | 减持 | |
| 520.33K | $785.69K | 0.00% | 持有 | |
| 485.73K | $733.45K | 0.00% | 减持 | |
| 327.07K | $493.87K | 0.00% | 新进 | |
| 327.07K | $493.87K | 0.00% | 新进 | |
| 291.67K | $440.42K | 0.09% | 持有 | |
| 283.12K | $427.52K | 0.00% | 持有 | |
| 232.97K | $351.79K | 0.00% | 减持 | |
| 194.11K | $293.10K | 0.00% | 持有 | |
| 194.11K | $293.10K | 0.00% | 持有 | |
| 159.04K | $240.27K | 0.00% | 减持 | |
| 153.74K | $232.15K | 0.00% | 增持 | |
| 118.00K | $178.19K | 0.00% | 增持 | |
| 100.00K | $151.00K | 0.00% | 持有 | |
| 77.66K | $117.00K | 0.00% | 新进 | |
| 62.87K | $94.94K | 0.00% | 减持 | |
| 52.21K | $78.84K | 0.00% | 新进 | |
| 46.25K | $69.83K | 0.00% | 增持 | |
| 45.46K | $68.64K | 0.10% | 持有 | |
| 44.22K | $66.77K | 0.00% | 新进 | |
| 42.28K | $63.84K | 0.00% | 增持 | |
| 41.40K | $62.51K | 0.00% | 新进 |
新建仓(Q2 2026)
- Viking Global Investors 2.60M 股 · $25.26M
- VIKING GLOBAL INVESTORS LP 2.60M 股 · $25.26M
- Blackstone Inc. 2.40M 股 · $23.31M
- Caligan Partners LP 1.74M 股 · $16.84M
- Samsara BioCapital, LLC 954.86K 股 · $9.26M
- Blue Owl Capital Holdings LP 874.54K 股 · $8.48M
- SILVERARC CAPITAL MANAGEMENT, LLC 525.00K 股 · $5.09M
- GEODE CAPITAL MANAGEMENT, LLC 353.85K 股 · $3.43M
- BOOTHBAY FUND MANAGEMENT, LLC 314.38K 股 · $3.05M
- Nantahala Capital Management, LLC 300.00K 股 · $2.91M
- ACUTA CAPITAL PARTNERS, LLC 260.42K 股 · $2.53M
- KVP Capital Advisors, LP 200.00K 股 · $1.94M
完全清仓(较上季)
- venBio Partners LLC 卖出 531.34K 股 · $3.42M
- Millennium Management 卖出 123.27K 股 · $793.86K
- MILLENNIUM MANAGEMENT LLC 卖出 123.27K 股 · $793.86K
- JANE STREET GROUP, LLC 卖出 39.50K 股 · $254.35K
- STATE STREET CORP 卖出 35.82K 股 · $230.71K
- PANAGORA ASSET MANAGEMENT INC 卖出 30.70K 股 · $197.72K
- Sanctuary Advisors, LLC 卖出 21.58K 股 · $138.98K
- OMERS ADMINISTRATION Corp 卖出 11.40K 股 · $73.42K
- OSAIC HOLDINGS, INC. 卖出 18 股 · $116
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Blue Owl Capital Holdings LP | 4.13M | 874.54K | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 2.88M | 3.56K | 3.53K | 3.56K | 4.92K | 42.28K | 3.56K | 900 | 160 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.81M | 981.82K | 207.69K | — | — | — | — | — | — |
| BlackRock Inc | 1.80M | 694.73K | 213.39K | 212.54K | 294.42K | 485.73K | 1.25M | 1.05M | 837.61K |
| Aberdeen Group plc | 935.72K | — | — | — | — | — | — | — | — |
| Sanofi | 672.78K | — | — | — | — | — | — | — | — |
| Franklin Resources | 2.04M | 2.00M | 520.33K | 520.33K | 520.33K | 520.33K | 520.33K | 520.30K | 520.30K |
| Geode Capital Management | 752.56K | 353.85K | 101.69K | 101.12K | 110.90K | 159.04K | 410.46K | 315.76K | 308.93K |
| UBS Group AG | 396.74K | 184.02K | 1.53K | 36.87K | 21.14K | 3.34K | 43.08K | 35.38K | 6.62K |
| Propel Bio Management, LLC | 696.44K | 696.44K | 146.37K | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 250.00K | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 268.80K | 148.39K | 32.81K | — | — | — | — | — | — |
| STATE STREET CORP | 363.46K | — | 35.82K | 35.82K | 59.82K | 62.87K | 171.78K | 164.78K | 86.56K |
| Nantahala Capital Management, LLC | 300.00K | 300.00K | — | — | — | — | — | — | — |
| Revelation Capital Management, LLC | 299.31K | 299.31K | 299.31K | 299.31K | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 268.61K | 31.11K | — | — | — | — | — | — | — |
| Squarepoint Ops LLC | 109.83K | 14.86K | — | — | — | 41.40K | — | — | — |
| TD ASSET MANAGEMENT INC | 60.57K | — | — | — | — | — | — | — | — |
| Simplify Asset Management Inc. | 101.36K | 101.36K | 23.23K | — | — | — | — | — | — |
| Renaissance Technologies | 74.08K | 151.00K | 80.04K | 116.20K | 79.15K | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold ARTV?
As of 2026-Q2, 75 institutional funds reported holding ARTV (ARTIVA BIOTHERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $420.61M.
How many shares of ARTV do institutions own?
13F filers reported 43.36M shares of ARTV, worth $420.61M in aggregate at the end of 2026-Q2.
Is institutional ownership of ARTV rising or falling?
Share counts moved +82.6% versus the prior quarter — accumulation.
Who are the top institutional holders of ARTV?
The largest 13F holders are RA CAPITAL MANAGEMENT, L.P., Blue Owl Capital Holdings LP, Fidelity Management & Research (FMR), Viking Global Investors, VIKING GLOBAL INVESTORS LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ARTIVA BIOTHERAPEUTICS INC?
The major shareholders of ARTIVA BIOTHERAPEUTICS INC (ARTV) by reported 13F value are RA CAPITAL MANAGEMENT, L.P., Blue Owl Capital Holdings LP, Fidelity Management & Research (FMR), Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 146 institutional holders.
Which legendary investors own ARTV?
1 of the legendary investors tracked on HoldingsHub report ARTV (ARTIVA BIOTHERAPEUTICS INC) in their latest 13F filings, led by Viking Global Investors. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on ARTV?
1 tracked superinvestors hold ARTV simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.